Sign in
CompletedNo phase

CCSV - Post Market Clinical Follow-up Study

Key facts

Who runs it
Medical University of Vienna
Where
Austria1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
50 people enrolled
Started
1 Jun 2024
Ended
31 Mar 2026
Type of study
Observational, 2 groups
Record updated
20 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • OHCA
  • Correct endotracheal intubation (seen by capnography)
  • The patient is being treated by the Vienna Emergency Medical Services within the scope of emergency ventilation
  • MEDUMAT Standard from Weinmann Emergency is used
  • Mechanical ventilation is performed according to the specified indications

Who cannot take part

  • Traumatic cardiac arrest
  • Patients eligible for eCPR (as defined by the standard operating procedure of the Emergency Medical Service Vienna)
  • Patients recovering (reaching sustained ROSC) before starting mechanical ventilation or in the first three minutes of it
  • Any other mechanical ventilation during the ongoing CPR before study inclusion
  • Suspected or known pregnancy
  • Clinically suspected (tension-)pneumothorax

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The main goal of this observational study is the evaluation of Chest Compression Synchronized Ventilation (CCSV) regarding oxygenation in terms of PaO2 assessed by routine blood gas analysis, hemodynamic effects, 30-day outcome and safety in comparison to Intermittent Positive Pressure Ventilation (IPPV) as data in humans is sparse especially in direct comparison to other ventilation modes.

Read full original descriptionShow less

Cardiac arrest patients in Vienna, Austria will be preclinically randomized (IPPV and CCSV) and ventilated accordingly during CPR. Differences in oxygenation, decarboxylation, systemic perfusion and cerebral oxygenation, the patient's 30-day outcome as well as ventilator-associated adverse events (e.g., pneumothorax) will be recorded and analyzed.

The 2 groups in the trial

  • IPPV

    Cardiac arrest patients ventilated with IPPV

  • CCSV

    Cardiac arrest patients ventilated with CCSV

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Chest Compression Synchronized Ventilation (CCSV) - An Exploratory Post Market Clinical Follow-up Study
Record updated
20 July 2026